We will notify you when it becomes available
How clinicians might think about this (risk vs benefit) GLP-1 receptor agonists have benefits that are not small: strong glucose lowering in many patients weight loss benefits in certain populations, cardiovascular risk reduction sometimes improved adherence compared to multiple daily pills because of weekly dosing options So for many patients, the benefit side of the equation is heavy
It reduces glucagon, decreasing excess glucose production from the liver
They are pre-dosed, meaning each troche contains a fixed milligram amount
Promoting glycogen breakdown: It encourages the conversion of stored glycogen into glucose, making energy readily available
Understanding this side effect, its frequency, and management strategies helps patients continue treatment safely while minimizing digestive symptoms